A clinical study to check effect of two drugs bruhatlashunpinda and rasnasaptak kwatha on patients with manyastambha with special reference to cervical spondylosis.
- Conditions
- Health Condition 1: M471- Other spondylosis with myelopathy
- Registration Number
- CTRI/2022/08/044780
- Lead Sponsor
- Dr Prachi Patwari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Well diagnosed patients of manyastambha (Cervical spondylosis).
2.Subjects having neck pain with or without radicular symptoms paresthesia since more than two months.
3.Cervical spondylitis confirmed by radiological assessment (X ray cervical vertebrae AP and lateral view.
4.Subjects were willing to give informed consent and ready to comply with the protocol.
5.Subjects who are ready to provide regular follow ups till completion of the study.
1.Known cases of trauma of neck, local wound and infection over neck, cervical rib syndrome, any spinal cord disorders other than cervical spondylosis & myelopathy.
2.Known cases of shoulder and elbow musculoskeletal problems, fracture of spine and upper limb.
3.Known cases of inflammatory arthritis.
4.Subjects who use any other investigational drug within one month prior to randomization.
5.Known cases of Tuberculosis, HIV, Ischemic heart disease, Cancer.
6.Known cases of Hypertension, Hyperacidity, Peptic ulcer, Duodenal ulcer.
7.Pregnancy and Lactation.
8.Other conditions, which in the opinion of investigators, makes the patient unsuitable for enrollment or could interfere with his/her participation in, and completion of the protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Visual Analog Scale, Neck Disability Index, Goniometry readings and neck pain, stiffness, restricted neck movements.Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil